Prevention and Treatment of AKI VEXUS Guided Post Cardiac Surgery
Recruiting
N/A
Interventional Study
Acute Kidney Injury
Cardiac Surgery Associated - Acute Kidney Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 304 (estimated)
- Sponsor
- Onassis Cardiac Surgery Centre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main goal of this clinical trial is to learn if evaluation by ultrasound of venous congestion of liver and kidneys can guide treatment and prevent and treat acute kidney injury post cardiac surgery (CSA-AKI).
Participants will:
Be evaluated by liver and kidney veins ultrasound (treatment group) or a placebo post CSA-AKI.
Fluid management for the treatment group will be based on a score that…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients in the Cardiac Surgery ICU who develop acute kidney injury according to KDIGO criteria, within 48 hours of ICU admission after cardiac surgery
* Elective and non-elective cardiac surgery.
Exclusion Criteria:
* Patient refusal
* Severe chronic renal failure (GFR\<15 …
Contacts